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1 |  INTRODUCTION
Hard metal is an alloy based on tungsten carbide (WC) and co-
balt (Co). Occupational exposure during the production of hard 
metal is associated with several adverse health effects with the 
respiratory tract being one of the main targets.1 Prolonged expo-
sure to Co has also been shown to be associated with cardiomy-
opathy.2 Furthermore, Co is classified as possibly carcinogenic 
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Abstract
The neurotoxicity of hard metal-based nanoparticles (NPs) remains poorly under-
stood. Here, we deployed the human neuroblastoma cell line SH-SY5Y differentiated 
or not into dopaminergic- and cholinergic-like neurons to study the impact of tung-
sten carbide (WC) NPs, WC NPs sintered with cobalt (Co), or Co NPs versus soluble 
CoCl2. Co NPs and Co salt triggered a dose-dependent cytotoxicity with an increase 
in cytosolic calcium, lipid peroxidation, and depletion of glutathione (GSH). Co NPs 
and Co salt also suppressed glutathione peroxidase 4 (GPX4) mRNA and protein ex-
pression. Co-exposed cells were rescued by N-acetylcysteine (NAC), a precursor of 
GSH, and partially by liproxstatin-1, an inhibitor of lipid peroxidation. Furthermore, 
in silico analyses predicted a significant correlation, based on similarities in gene ex-
pression profiles, between Co-containing NPs and Parkinson's disease, and changes 
in the expression of selected genes were validated by RT-PCR. Finally, experiments 
using primary human dopaminergic neurons demonstrated cytotoxicity and GSH de-
pletion in response to Co NPs and CoCl2 with loss of axonal integrity. Overall, these 
data point to a marked neurotoxic potential of Co-based but not WC NPs and show 
that neuronal cell death may occur through a ferroptosis-like mechanism.
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to humans (group 2B) by the International Agency for Research 
on Cancer (IARC). In recent years, the use and production 
of hard metal has increased considerably. One such example 
is tire studs, with pins made of WC sintered with Co, used in 
many countries during the winter to improve gripping power 
on icy roads. However, their use is controversial as hard metal 
nanoparticles (NPs) are released into the environment due to the 
wear of such studs, which could lead to adverse health effects.3
Co has also been widely used in biomedical applications 
including in hip prostheses and this, in turn, may give rise to in-
ternal exposure to Co resulting in significant systemic concen-
trations of Co.4 Indeed, health concerns have been raised due to 
the release of potentially toxic levels of Co (and chromium, Cr) 
by hip implants used in orthopedic surgery.5,6 In a recent study, 
Scharf et al7 performed histological and elemental analyses in 
Cr and Co exposed patients undergoing hip revision surgery 
and were able to document a positive correlation between the 
amounts of Cr3+ and Co2+ ions in tissues and oxidative damage. 
Furthermore, anecdotal evidence has been put forward for a 
link between the corrosion of metal-bearing hip prostheses and 
neurological symptoms.8 In another case report, the authors 
found a correlation between Parkinson's disease (PD) symp-
toms and prosthesis wear-induced hypercobaltemia.9 However, 
despite these case reports, there are few systematic studies on 
the neurotoxicity of Co or hard metal-based NPs. Bastian et al10 
examined acute cytotoxicity of WC and WC-Co (10 wt% Co) 
NPs in various human cell lines as well as in rat neuronal and 
glial cells and found that WC-Co NPs significantly decreased 
viability in oligodendrocytes and astrocytes when compared 
with WC NPs. More recently, Zheng et al11 have shown that 
Co NPs and CoCl2 caused neurotoxicity in rats as well as in 
PC-12 cells (derived from a rat pheochromocytoma) with 
NPs showing greater toxic potency when compared to CoCl2. 
Notwithstanding, the studies performed to date fall short in 
terms of providing a detailed understanding of the mechanism 
of neurotoxicity of Co-based particles and the potential relation 
of these materials with neurodegenerative diseases in humans. 
Therefore, we investigated the potential impact of WC, WC-Co 
(5 wt% Co), and Co NPs in a human neuroblastoma cell line 
in comparison to CoCl2 and elucidated the underlying mech-
anism of cell death in these cells. Furthermore, we explored 
the relation of Co-based NPs with PD by using an in silico 
approach12 coupled with in vitro validation in our cell model, 
and we verified our findings in primary human dopaminergic 
neurons cultivated ex vivo. Overall, our results provide new in-
sights regarding the neurotoxicity of Co.
2 |  MATERIALS AND METHODS
2.1 | Particle characterization
WC, WC-Co, and Co NPs were purchased from American 
Elements (Los Angeles, CA). WC-Co NPs (product code 
WC-CO-03 MNP. 200N; <200 nm, 40-80 nm) contained 5 
wt% Co and had a purity of 99.9%. According to the manu-
facturer, Co was precipitated on WC NPs via wet chemistry 
to produce WC-Co NPs. Co NPs (product code CO-M-028M-
NP.100N, <100 nm) had a purity of 99.8%. WC NPs (product 
code W-C-03M-NP.100N, <100 nm) had a purity of 99.9%. 
Water soluble Co (II) chloride (CoCl2·6H2O; Sigma) was in-
cluded as ionic control at equivalent concentrations of the Co 
NPs. NP dispersions were made freshly at stock concentration 
of 1 mg/mL in endotoxin-free water followed by 4 minutes 
sonication for WC and Co NPs and 7  minutes for WC-Co 
NPs at 10% amplitude using a probe sonicator (Branson 
Sonifier S-450D, Branson Ultrasonics Corp., Danbury, CT). 
Subsequent dilutions were immediately prepared in cell me-
dium prior to exposure. Endotoxin content was evaluated 
by using the chromogenic Limulus amebocyte lysate (LAL) 
assay (Lonza, Walkersville, MD), as described.13 The sam-
ples were endotoxin-free (data not shown). The primary 
size of the NPs was determined by transmission electron 
microscopy (TEM)14 and representative images are shown. 
Hydrodynamic size distribution and zeta potential of NP sus-
pensions (50 µg/mL) in water and two different cell culture 
media (see below) was measured at 1 and 24 hours by dy-
namic light scattering (DLS) using a Malvern Zetasizer Nano 
ZS instrument equipped with 4.0 mW, 633 nm laser (Model 
ZEN3600, Malvern Instruments Ltd., UK) as described.13 
NP stability and sedimentation in cell media was determined 
by photon cross-correlation spectroscopy (PCCS).15 In brief, 
PCCS (NanoPhox, Sympatec) was used to analyze NP disper-
sions (50 μg/mL) immediately after dispersion (5 minutes), 
and after 1 and 24 hours. Triplicate samples were analyzed 
to obtain the size distribution patterns. Calibration was per-
formed using standard latex samples (20 ± 2 nm).
2.2 | Human neuronal cell line
The human neuroblastoma cell line (SH-SY5Y) was obtained 
from Sigma-Aldrich (cat no. 94030304) and cultured in 
DMEM/F12:MEME (1:1) cell medium (Sigma-Aldrich) sup-
plemented with heat-inactivated fetal bovine serum (FBS) 
(10%), glutamine (2 mM), penicillin and streptomycin, and 
nonessential amino acids (Sigma-Aldrich). The cell cul-
tures were regularly tested for mycoplasma contamination. 
SH-SY5Y cells were also differentiated into dopaminergic/
cholinergic-like neurons using retinoic acid (RA) (1  µM) 
(Sigma-Aldrich) in DMEM/F12 medium supplemented 
with glutamine (2 mM), penicillin and streptomycin, and N2 
growth factor supplement (ThermoFisher). SH-SY5Y cells 
were differentiated up to 6 days and cell medium of differen-
tiating cells was replenished after 3 days to ensure availability 
of optimal nutrients and differentiation factor for the growth 
of cells. Differentiation of cells was checked on the last day 
by expression analysis of selected genes used as markers for 
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dopaminergic (monoamine oxidase A [MAOA] and neuro-
genin 2 [NeuroG2]) and cholinergic neurons (choline acetyl-
transferase [CHAT] and solute carrier family 18 member A3 
[SLC18A3]) by using RT-PCR (see below). Cytotoxicity of 
NPs was evaluated before and after differentiation of SH-
SY5Y cells into cholinergic/dopaminergic neurons. To this 
end, SH-SY5Y cells were seeded at a density of 2.5 × 104 
cells/cm2 for undifferentiated cells and 1.25 × 104 cells/cm2 
for differentiating or differentiated cells. After 24  hours, 
particle dispersions were directly added to the cell cultures 
to achieve a final concentration of 0, 1, 5, 10, 20, 50, and 
100 μg/mL. The final volume used in 6- or 96-well plates was 
2.7 and 0.1 mL, respectively, in order to maintain the same 
μg/cm2 concentration between experiments. The exposure in 
undifferentiated and differentiated cells was maintained for 
24 hours; however, in differentiating cells, NPs were added at 
day 1 and cell medium was replenished after 3 days without 
adding NPs and the cells were then maintained up to day 6. 
To probe the mechanism of cell death induced by Co, cells 
were co-exposed with Co (20 and 50 µg/mL) and inhibitors 
of apoptosis (zVAD-fmk, 20 µM), necroptosis (necrostatin-1, 
30 µM), ferroptosis (liproxstatin-1, 10 µM), autophagy (wort-
mannin, 1 µM), as well as deferoxamine (10 µM). These in-
hibitors were all purchased from Sigma-Aldrich (Sweden). 
The cells were preincubated with the indicated inhibitors 
for 30 minutes prior to exposure to NPs or CoCl2. Loss of 
cell viability was determined by using the Alamar blue assay 
(ThermoFisher Scientific).13 Data are derived from three in-
dependent experiments each performed in triplicate.
2.3 | Primary human neurons
Predifferentiated dopaminergic neurons (or DOPA precur-
sors) (ASE-9323) derived from a karyotype normal human 
induced pluripotent stem cell (iPSC) line were purchased 
from Applied StemCell (Milpitas, CA). The cells were 
cultured and differentiated to produce primary dopamin-
ergic neurons (mature DOPA neurons) by applying the 
optimized dopaminergic maturation medium and supple-
ments provided by Applied StemCell (ASE-9323DM). 
Briefly, before seeding the cells the culture vessels were 
coated with 20 μg/mL of poly-L-ornithine (Sigma-Aldrich) 
and vessels were incubated for 2 hours at 37°C (5% CO2). 
Next, the vessels were rinsed with ultrapure water and 
10 μg/mL of laminin solution (ThermoFisher) was added 
to cover the bottom of each vessel followed by another in-
cubation for 2 hours at 37°C (5% CO2). Afterward, laminin 
was aspirated and DOPA precursors cells (4.0 × 104 cells/
cm2) were seeded evenly in the vessels without further 
washing and cells were placed in the cell culture incubator. 
During the entire process of dopaminergic neuron matura-
tion, two types of complete medium were used as provided 
by the supplier: Medium A (DOPA Medium + Supplement 
A) was used for culture from day 0-4; whereas Medium 
B (DOPA Medium  +  Supplement B) was used for cul-
ture from day 4-12. The cell medium was changed every 
other day up to 12 days. At 12 days, the cells were immu-
nostained with anti-TH and Tuj-1 antibodies (see below) 
to confirm the differentiation status. NPs and Co salt expo-
sure to the cells was performed at day 4 and day 12 in the 
cell media indicated above and exposures were maintained 
for 24 hours. After exposure, cell viability and glutathione 
(GSH) content was determined by using Alamar blue and 
GSH-GlowTM assays, respectively. Control and treatment 
groups were also imaged under an optical microscope to 
capture morphological changes.
2.4 | Inductively coupled plasma mass 
spectrometry (ICP-MS)
SH-SY5Y cells were seeded at 0.5 × 106 cells per well 1 day 
before the experiment and then exposed for 24  hours to 
freshly dispersed NPs at a final concentration of 10 µg/mL. 
After exposure, the cells were collected by trypsinization 
followed by washing three times with PBS and then pro-
cessed for metal analysis by ICP-MS. For Co release in cell 
medium and water, NPs were freshly dispersed at 10 µg/
mL and incubated for 0 and 24, at 37°C. After incubation, 
the particle dispersions were centrifuged at 15,000  rpm, 
1 hour (0°C) and the supernatants were carefully collected. 
Non-centrifuged dispersions were also collected in order to 
measure the total amount of W or Co added. The samples 
were digested in 32% of HNO3 for at least 48 hours to en-
sure complete mineralization. Before analysis, all the sam-
ples were diluted to reach approximately 2% of HNO3. For 
all samples, Co and W isotopes were quantified using an 
iCAP Q ICP-MS (Thermo Scientific) instrument in KED 
mode. Calibration standards of 0.1, 1, 10, and 100 μg/L Co 
and W were prepared using a 1000 mg/L reference standard 
(Spectrascan). Samples spiked with 12.25 μg/L of indium 
were used as an internal standard with a range of recovery 
between 80% and 100%. Each sample was injected at least 
three times and the RSD acceptance was set at 15%. Cell 
uptake results were normalized according to the cell num-
ber and expressed as pg Co/cell. Co release was expressed 
as the percentage Co released in cell medium or water in 
relation to the amount of total Co added.
2.5 | Transmission electron microscopy
To visualize cellular uptake of NPs and to assess any ultra-
structural changes, cells were incubated with 10  μg/mL of 
WC, WC-Co, and Co NPs for 24 hours. Samples were then 
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processed for TEM.16 Briefly, samples were washed three 
times with serum-free medium and fixed with 4% of glut-
aldehyde in 0.1  M of sodium phosphate buffer pH 7.4 for 
1 hour at 4°C. Following postfixation in 1% of OsO4 in 0.1 
sodium phosphate buffer for 1  hour at 4°C, the samples 
were serially dehydrated in gradient of ethanol followed by 
acetone and LX-112 infiltration and finally embedded in 
LX-112. Ultrathin sections (approximately 50-80 nm) were 
prepared using a Leica EM UC6, contrasted with uranyl ac-
etate followed by lead citrate, and examined in Hitachi HT 
7700 electron microscope (Hitachi). Images were acquired 
using a 2k × 2k Veleta CCD camera (Olympus).
2.6 | Flow cytometry
For the analysis of mitochondrial membrane potential, cells 
were seeded in 6-well plates and exposed to Co NPs and 
CoCl2 at the indicated concentrations for 1 and 6 hours. After 
exposure, SH-SY5Y cells were incubated for 30 minutes at 
37°C in the dark with the cell permeable, fluorescent probe, 
tetramethylrhodamine, ethyl ester (TMRE) (25  nM). Cells 
were then trypsinized, neutralized with cell culture medium, 
and the cell pellet was resuspended in HEPES buffer (10 mM 
HEPES-NaOH, 150  mM NaCl, 5  mM KCl, 1  mM MgCl2, 
and 1.8  mM CaCl2, pH 7.4). Fluorescence was recorded 
using a BD LSRFortessa flow cytometer operating with BD 
FACS DIVA software (BD Biosciences). Cellular debris was 
gated out and ten thousand events were collected for each 
sample. Data were analyzed using FCS express software 
(BD Biosciences). For determination of intracellular cal-
cium levels, cells exposed with the indicated concentrations 
of NPs for 1 hour and then incubated with 5 µM of Fluo-4-
acetoxymethyl ester (Fluo-4 AM, ThermoFischer Scientific, 
in 3% of DMSO) for 30 minutes at 37°C. Fluorescence was 
recorded using a BD LSRFortessa flow cytometer operating 
with BD FACS DIVATM software (BD Biosciences). In order 
to investigate whether chelation in intracellular and/or extra-
cellular Ca2+ can modulate the toxicity of Co NPs and salt, 
SH-SY5Y cells were co-exposed to Co NP (20 and 50 μg/
mL) and EDTA (1 mM, Sigma), EGTA (1 mM, Sigma), and 
BAPTA-AM (5  µM, ThermoScientific) for 24  hours, and 
cytotoxicity was evaluated using Alamar blue assay. Cells 
were preincubated with chelators for 30 minutes prior to Co 
exposure.
2.7 | Confocal microscopy
SH-SY5Y cells were grown on coverslips in 24-well plates 
and then exposed to the Co NPs and CoCl2 at 20 µg/mL for 
12 hours. After exposure, the cells were washed thrice and 
incubated with 0.5 µM of MitoTracker Red (Invitrogen) for 
30 minutes. The cells were then fixed in 3% of paraformalde-
hyde in phosphate buffer at room temperature for 20 minutes 
followed by washing with PBS. The coverslips were mounted 
on glass slides with VECTASHIELD Antifade Mounting 
Medium with DAPI (Invitrogen) and a Zeiss LSM880 confo-
cal microscope equipped with a laser diode 405 nm, argon 
laser 488 nm, and HeNe1 543 nm was used to analyze the 
samples. Additionally, SH-SY5Y cells were grown on cov-
erslips in 24-well plates and exposed to the mitochondrial 
uncoupling agent, CCCP (carbonyl cyanide m-chlorophenyl 
hydrazine) (Sigma-Aldrich) (50 µM) or Co NPs and CoCl2 
at 50 µg/mL for 6 hours. SH-SY5Y cells were then washed 
and incubated for 30 minutes at 37°C in the dark with the 
cell permeable, fluorescent dye, tetramethylrhodamine, ethyl 
ester (TMRE) (25  nM) that is sequestered by active mito-
chondria. To monitor lipid peroxidation, SH-SY5Y cells 
were loaded with 2.5  μM of the oxidation-sensitive probe 
C11-BODIPY581/591 for 30 minutes. After washing with PBS, 
cells were fixed in 4% of paraformaldehyde and washed again 
and mounted on glass slides using VECTASHIELD Antifade 
Mounting Medium with DAPI. Confocal imaging was per-
formed as described above.
2.8 | Immunocytochemistry
The differentiation of DOPA precursor cells to mature 
DOPA neurons was confirmed by immunostaining of 12-
day differentiated cells for tyrosine hydroxylase (TH) and 
anti-β3-tubulin (Tuj-1) expression. To this end, cells were 
seeded at a density of 4.0  ×  104 cells/cm2 and grown on 
glass coverslips in 24-well plates. At day 12, cells were 
washed and fixed in 4% of formaldehyde for 15  minutes 
at room temperature. Then, coverslips were washed in 
PBS and permeabilized in 0.1% of Triton-X 100 (Sigma-
Aldrich) for 15 minutes, followed by blocking with 10% of 
goat serum (Abcam) and 0.1% of Triton-X100 for 60 min-
utes. Then, coverslips were incubated with mouse anti-
Tuj-1 antibody (Sigma-Aldrich) or rabbit anti-TH antibody 
(Abcam) in antibody buffer (8% of goat serum and 0.1% 
of Triton-X-100) overnight at 4°C. Coverslips were then 
rinsed in PBS and incubated with secondary antibodies, goat 
anti-mouse antibody 680 Alexa conjugated (Abcam) and 
goat anti-rabbit antibody 480 Alexa conjugated (Abcam), 
for 1 hour. Coverslips were mounted on glass slides using 
DAPI-containing mounting medium (Invitrogen) and im-
aged using a Zeiss LSM880 microscope.
2.9 | Spectrophotometric assays
For reactive oxygen species (ROS) production, cells were 
seeded in a 96-well plate 1 day before the experiment to allow 
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cells to adhere. The following day, cells were loaded with 
10 μM of H2-DCF (Invitrogen) and incubated for 30 minutes 
in the dark, at 37°C and 5% CO2. The cells were washed at 
least twice after completion of incubation and supplemented 
with fresh cell medium. DCF-loaded cells were exposed at the 
indicated concentrations of Co NPs and salt for 1 hour. DCF 
fluorescence (ex/em—485/535 nm) was recorded using the 
Tecan Infinite® 200 plate reader (Männedorf, Switzerland). In 
order to investigate whether increased ROS is involved in the 
toxicity of Co NPs and salt, SH-SY5Y cells were co-exposed 
to Co NP (20 and 50  μg/mL) and ascorbic acid (100  µM) 
or mitoTEMPO (100  µM) (both from Sigma-Aldrich) for 
12 hours, and cytotoxicity was evaluated using Alamar blue 
assay, as described above. For GSH levels, SH-SY5Y cells 
(1.0 × 104 cells/well) were seeded in 96-well plate and ex-
posed with 5, 10, and 20 µg/mL of WC, WC-Co, Co NPs, and 
Co for 6 hours. After exposure, cell medium was discarded 
and samples were analyzed by using the GSH-GlowTM assay 
(Promega). Briefly, GSH-GlowTM reagent was added to wells 
and incubated for 30 minutes at room temperature followed 
by adding luciferin detection reagent. The luminescence was 
measured using a Tecan Infinite® 200 plate reader. In order 
to investigate whether alterations in intracellular GSH can 
modulate the toxicity of Co NPs and salt, SH-SY5Y cells 
were co-exposed to Co NP or Co ions (20 and 50 μg/mL) and 
N-acetylcysteine (NAC) (2.5 mM) (Sigma-Aldrich) or GSH 
(0.5 mM) (Sigma-Aldrich) for 12 hours, and cytotoxicity was 
evaluated using Alamar blue assay (see above). Cells were 
preincubated with NAC and GSH for 30 minutes before the 
administration of Co NPs or CoCl2.
To complement the results obtained using Fluo-4 AM, 
SH-SY5Y cells (6.0  ×  104 cells/well) were seeded in 96-
well plates and exposed to 20 and 50 µg/mL of WC, WC-
Co, Co NPs, and Co salt for 1  hour. Cells were exposed 
in DMEM/F12:MEM or calcium-free DMEM/F12:S-MEM 
(ThermoFischer Scientific), as indicated. Then, the cell me-
dium was discarded and samples were analyzed by using 
the Fura-2 no-wash calcium assay kit (Abcam, Germany) 
according to the manufacturer's instructions. Briefly, the 
ratiometric Fura 2 dye diluted in loading buffer (Pluronic 
F127 plus in HHBS buffer) was added to each well and 
samples were incubated for 60 minutes at 37°C (5% CO2) 
followed by incubation for 20  minutes at room tempera-
ture. The fluorescence was detected at Ex/Em 340/510 and 
Ex/Em 380/510 by using the SpectraMax MiniMax 300 
imaging cytometer (Molecular Devices) (courtesy of Dr 
G. Sotiriou). The ratio of Ex 340/380 plotted to indicate 
changes in Ca2+ levels. For quantification of lipid peroxi-
dation, SH-SY5Y cells were exposed to Co NPs and CoCl2 
at the indicated concentrations for 6 hours in the presence 
and absence of liproxstatin-1 (10  µM). After exposure, 
cells were loaded with 2.5  μM of the oxidation-sensitive 
probe C11-BODIPY581/591 (Thermo Fisher Scientific) for 
30 minutes and then washed with PBS. Fluorescence was 
measured at 484/510  nm (green) and 581/610  nm (red) 
using the SpectraMax® MiniMax 300 imaging cytometer. 
The percent increase in relative fluorescence was calculated 
with respect to untreated controls.
2.10 | RT-PCR
Cells were seeded in 6-well plates and exposed to RA as de-
scribed above (for differentiation marker studies) or NPs at 
the indicated concentrations for 24  hours (undifferentiated 
SH-SY5Y cells) or 6 days (differentiated SH-SY5Y cells). 
After exposure, cells were washed with PBS and subjected 
to RNA isolation. RNA isolation was performed using the 
QIAGEN RNeasy Mini Kit according to the manufacturer's 
protocol. The quality and yield of RNA was checked using 
NanoDrop (ThermoScientific). cDNA was synthesized 
using iScriptTM Reverse Transcriptase Kit (Bio-Rad) using 
a thermal cycler (Bio-Rad). RT-PCR was performed using 
SYBR-Green based 96-well primePCR custom plates (Bio-
Rad) for the following genes: MAOA, NeuroG2, CHAT, 
SLC18A3, glutathione peroxidase 4 (GPX4), solute carrier 
family 7 member 11 (SLC7A11), RAF1, NEFH, RPLP1, 
and GAPDH (Table S1). Each RT-PCR reaction contained 
1 µL of cDNA, 1x SsoAdvanced universal SYBR supermix 
(Bio-Rad) and 1x PrimePCR assay dried in well. Reactions 
were performed in three technical replicates. RT-PCR was 
run using the AB7500 RT-PCR (Applied Biosystems) at the 
following conditions: activation at 95°C for 2 minutes, 40 cy-
cles of denaturation at 95°C for 5 s, and annealing/elongation 
at 60°C for 30 s. The fold change in the gene expression was 
obtained by calculating ΔΔCt value with respect to GAPDH 
or RPLP1 as reference control.
2.11 | Western blot
Cell lysates were prepared by incubating cells in RIPA 
buffer [Tris-HCl (pH 7.4), NaCl (150  mM), NP40 (1%), 
Na-deoxycholate (0.25%), EDTA (1mM), dithiothreitol 
(1  mM), phenylmethylsulfonyl fluoride (1mM)] with a 
protease inhibitor cocktail (1x) added freshly just before 
the use for 3 hours, as described.17 Cell lysates were cen-
trifuged at 13000xg for 20 minutes and supernatants were 
collected for western blot. The protein concentration was 
measured by Bradford assay. Thirty µg of protein was 
loaded for each sample and proteins were separated by run-
ning an SDS-PAGE (4%-12% Bis-Tris gel). Proteins were 
transferred to PVDF membranes and incubated overnight 
with primary antibody at 1:1000. The rabbit polyclonal pri-
mary antibody against GPX4 was purchased from Abcam 
(Sweden) and a mouse anti-GAPDH antibody (Ambicon) 
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was used as a loading control. Membranes were washed 
and incubated with a goat anti-rabbit secondary antibody 
(1:15  000) for 1  hour. Fluorescently labeled anti-mouse 
or anti-rabbit secondary Ab were procured from LI-COR 
Biosciences (Lincoln, NE). Blots were scanned and im-
aged using the LI-COR Biosciences system following the 
manufacturer's instructions. The results were quantified by 
dividing the signal of the tested protein in relation to the 
loading control.
2.12 | In silico transcriptomics
To explore potential associations between NPs and human 
diseases, we employed insideNANO (“Integrated Network of 
Systems Biology Effects of Nanomaterials”), a web-based tool 
(publicly available at http://inano.bioby te.de) that highlights 
connections between phenotypic entities based on their effects 
on gene expression.12 The tool comprises gene expression data 
corresponding to four different entities (ie, NPs, drugs, chemi-
cal substances, and human diseases), derived from scientific 
databases as described in.12 Gene expression data for NPs were 
retrieved from NanoMiner, a transcriptomics database encom-
passing in vitro transcriptomics profiles.18 RT-PCR-based 
validation (above) focused on those genes displaying the same 
directionality for Co-containing NPs and 1-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine (MPTP), a chemical known to cause 
PD-like symptoms. To this end, SH-SY5Y cells differentiated 
with RA for 6 days were utilized.
2.13 | Statistics
The results shown are derived from experiments per-
formed at least three times. Data are presented as mean 
values ± SD GraphPad Prism 5 (GraphPad Inc) was used 
for statistical analysis. One-way ANOVA followed by 
Dunnett's or Tukey's post hoc analysis was used for the 
analysis of statistical significance, and P < .05 was consid-
ered significant.
3 |  RESULTS
3.1 | Nanoparticle characterization and Co 
release
To understand the behavior of the NPs in relevant cell 
media, hydrodynamic size, zeta potential, particle stability 
(changes in size distribution with time), and particle dis-
solution/Co release were evaluated for the NPs. Figure S1 
shows the results for WC, WC-Co, and Co NPs in deion-
ized water and cell culture media (note that different cell 
media are used for undifferentiated and differentiated cells, 
see below). TEM revealed that WC and Co-based NPs were 
heterogeneously distributed below the 100 nm size range 
(Figure S1A-C). WC and WC-Co NPs were found to be 
more agglomerated than Co NPs. The hydrodynamic sizes 
of WC and Co-based NPs in water and in differentiated cell 
medium were in the range of 400 to 900 nm (Figure S1D-
F). The average size of WC and WC-Co NPs agglomer-
ates was reduced in the serum-containing undifferentiated 
cell medium. We noted a higher average size of the NPs at 
1 hour due to the presence of agglomerates. However, at 
24  hour, these larger sized agglomerates had sedimented 
from the dispersion yielding a lower average size of the 
remaining agglomerates in solution. Sedimentation of the 
NPs was further corroborated by reduced count rates in so-
lution with time at 5  minutes, 1, and 24  hours by PCCS 
(Figure S1J-L). The results showed that the count rates in 
dispersion were drastically reduced at 24 hours indicative 
of sedimentation of the NPs. The zeta potentials of the NPs 
were in the range of −8 to −35 mV (WC > WC-Co > Co 
NPs) (Figure S1G-I). The zeta potential of the WC and 
WC-Co NPs was reduced in cell culture media with serum. 
Table S2 shows the release of Co from NPs. Following 
incubation of WC-Co and Co NP in water and the undif-
ferentiated cell medium at 37°C (10 μg Co/mL), 11% and 
35% (in water), and 80% and 15% (in cell medium), respec-
tively, of total added Co was detected in solution immedi-
ately after dispersion at 0 hour. This is an effect of rapid 
dissolution mechanisms and the fact that dissolution takes 
place already during the sonication of stock solutions At 
24 hours, 61% and 73% (in water), and 77% and 96% (in 
cell medium), respectively, of total added Co was detected 
in solution (Table S2), in line with previous work showing 
near-complete release of Co in synthetic surface water.14
3.2 | Neurotoxicity of Co-containing NPs
SH-SY5Y cells were differentiated by using RA (1 µM) up 
to 6 days as shown previously.19 At day 6, these cells ex-
hibited extended neurites typically seen in mature neurons 
(Figure 1A-F) and expressed specific markers of dopaminer-
gic as well as cholinergic neurons, as determined by RT-
PCR (Figure 1H). The undifferentiated, differentiating, 
and differentiated SH-SY5Y cells were exposed to WC, 
WC-Co, and Co NPs versus CoCl2. The undifferentiated 
and differentiated cells were exposed for 24  hours and 
dose-dependent toxicity was observed for Co NPs and 
CoCl2 in both cell models (Figure 1G,I). WC-Co NPs 
showed significant toxicity toward differentiated cells only 
at the highest dose (100 μg/mL). However, WC NPs were 
nontoxic to the cells. In addition, to study cells undergoing 
differentiation, NPs or Co salt were added at day 1 and cell 
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medium was replenished after 3 days without adding NPs 
and cells were then maintained up to day 6 (Figure S2A). 
To allow for a better comparison with the undifferentiated 
cells, cytotoxicity was also determined in undifferentiated 
cells at 72 hours after continuous exposure to NPs versus 
CoCl2, or in undifferentiated cells exposed for 72  hours 
(A)
(G)
(H)
(I)
(B)
(C)
(D)
(E)
(F)
8 |   GUPTA eT Al.
and then maintained for another 72 hours in fresh medium 
without NPs (Figure S2B,C). This extended exposure to Co 
caused a similar degree of toxicity as in the differentiating 
cells. Overall, with regard to Co NPs and CoCl2, our find-
ings suggest that undifferentiated cells are more suscepti-
ble than cells differentiated into neuronal-like cells.
3.3 | Uptake of NPs in neuronal cells
TEM and ICP-MS was performed to understand cellular 
uptake and ultrastructural changes in SH-SY5Y cells fol-
lowing NP exposure. TEM micrographs clearly showed that 
WC, WC-Co, and Co NPs were internalized by the cells; 
furthermore, Co NPs were visualized in endosome-like 
vesicles (Figure 2A-L). It is interesting to note that intact 
Co NPs were present in the cells at 24 hours even though 
these NPs were found to undergo dissolution in cell culture 
medium (Figure 2J). Some mitochondria appeared swollen 
and degenerated following exposure to Co NPs (Figure 2K). 
In addition, fibrillary structures were noted in the cytoplasm 
of Co NP-exposed cells; such cytoplasmic changes are com-
mon in neurodegenerative disorders.20 We did not observe 
any morphological changes of the nucleus. Furthermore, 
cellular content of tungsten and Co was assessed by 
ICP-MS 24 hours after exposure to WC, WC-Co, and Co 
NPs (Figure 2M-N). The cellular content of Co reached 5 pg 
Co/cell after Co NP exposure, which was about four times 
higher than the amount of Co in cells exposed to the equiva-
lent amount of CoCl2 (approximately 1  pg Co/cell), sug-
gesting that the NPs bring more Co into cells (the so-called 
Trojan horse effect).
3.4 | Role of ROS and calcium homeostasis
Next, cellular ROS levels were studied in order to explore 
the potential role in Co toxicity. A dose-dependent increase 
in cellular ROS levels, as determined by using the cell per-
meable probe H2-DCF, was observed following exposure 
of non-differentiated cells to Co NPs for 1 hour, while the 
impact of CoCl2 was considerably less pronounced (Figure 
3A-B). Co NPs and CoCl2 did not elicit any drop in the mi-
tochondrial membrane potential at 1 hour (data not shown). 
After 6 hours of exposure, a modest effect was noted for 
the Co NPs whereas CoCl2 triggered a marked dissipa-
tion of the mitochondrial membrane potential (Figure 3C). 
Confocal imaging was performed to verify the results; 
CCCP was included as a positive control (Figure 3D-G). 
To evaluate whether ROS play a role in the cytotoxicity of 
Co NPs and CoCl2, cells were preincubated with ascorbic 
acid and mitoTEMPO (a specific scavenger of mitochon-
drial superoxide) and cytotoxicity was determined after 
24 hours. However, these experiments revealed no rescue 
of cell death (data not shown). Next, we determined cel-
lular calcium levels in cells using Fluo-4 AM and found 
that calcium levels were increased in cells exposed to Co 
NPs and CoCl2 (Figure 4A). To support these results, we 
applied the ratiometric dye, Fura 2, and incubated cells in 
regular cell culture medium (Figure 4B) versus calcium-
free cell culture medium (Figure 4C). Co NPs and CoCl2 
were both found to trigger an increase in cytosolic calcium 
(at 20 µg/mL). This was noted also in the case of calcium-
free medium (at a higher dose of 50 µg/mL). Modest or no 
effects were seen for WC and WC-Co NPs. Furthermore, 
calcium chelation by using different intra- and extracellular 
chelators prevented cell death after 24 hours of exposure 
to CoCl2 and, to a lesser degree, Co NPs (Figure 5A-F). 
It is noted that EGTA and EDTA have been shown to also 
chelate Co ions21 and this could potentially explain the 
marked effect in the case of CoCl2 (at 20 µg/mL, but not 
at 50 µg/mL) (Figure 5B,D). BAPTA-AM, on the contrary, 
is a calcium-specific chelator that acts as an intracellular 
calcium sponge, and was shown here to protect against Co 
NPs and CoCl2 (Figure 5E,F), though the response was less 
pronounced when compared to EDTA and EGTA.
3.5 | Depletion of GSH in Co-exposed cells
Non-apoptotic neuronal cell death is associated with GSH 
depletion.22 To further explore the cellular responses to Co, 
we determined GSH levels by using the luminescent-based 
GSH-Glow assay in which the reaction is catalyzed by GSH 
S-transferase. Co NP and CoCl2 exposed cells displayed a 
significant and dose-dependent decrease in GSH content 
(Figure 6A-B) while no significant change was observed in 
WC and WC-Co NPs exposed cells (data not shown). The Co 
F I G U R E  1  Co-induced neurotoxicity. Cytotoxicity of WC NPs, WC-Co NPs, Co NPs, and CoCl2 in undifferentiated SH-SY5Y cells versus 
SH-SY5Y cells differentiated for 6 days with retinoic acid (RA) prior to exposure. Optical micrographs of cells at day 6: A, control without RA, 
B, control with RA, C, WC NPs, D, WC-Co NPs, E, Co NPs, F, CoCl2. Arrows represent neurites that appeared after differentiation with RA. 
Arrowheads indicate dead cells. Metabolic activity, determined by using the Alamar blue assay, of undifferentiated cells after 24 hours (G), and 
differentiated cells after 24 hours (I). Data shown are mean values ± SD (n = 3). *P < .05, **P < .01, ***P < .001. H, Expression of dopaminergic 
and cholinergic markers after 6 days of RA (1 µM) induced differentiation. RT-PCR based analysis of the dopaminergic markers, MAOA 
(monoamine oxidase A) and NeuroG2 (neurogenin 2), and the cholinergic markers, CHAT (choline acetyltransferase) and SLC18A3 (solute carrier 
family 18 member A3). Data shown are mean values ± SD (n = 2)
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F I G U R E  2  Cellular uptake of tungsten and Co-containing NPs in undifferentiated SH-SY5Y cells. A-L, TEM micrographs show cellular 
uptake and ultrastructural changes in SH-SY5Y cells after 24 hours of exposure with NPs at 10 µg/mL; A-C, control, D-F, WC NPs, G-I, WC-Co 
NPs, and J-L, Co NPs. mt—mitochondria, nu—cell nuclei. Red arrows point to abnormal mitochondria; arrowheads indicate the NPs. Scale bars 
are shown in each image. M-N, Cellular concentration of Co and W in cells exposed to NPs or CoCl2 at 24 hours, as determined by ICP-MS. Data 
shown are mean values ± SD (n = 3). *P < .05, **P < .01, ***P < .001
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salt showed the strongest effect as GSH dropped to almost 
undetectable levels within 6 hours after exposure at 10 µg/
mL. Co-exposure with NAC (a GSH precursor) significantly 
reversed the cell death triggered by Co NPs (Figure 6C). 
Furthermore, NAC and GSH afforded partial protection of 
cells against CoCl2 at 12 hours (Figure S3A,B) and 24 hours 
(Figure S3E,F).
3.6 | Co triggers ferroptosis-like cell death
To further enhance our understanding of the Co-mediated 
cell death mechanism, the impact of inhibitors of apopto-
sis, necroptosis, ferroptosis, and autophagy were tested. No 
rescue was seen following co-exposure of cells to Co NPs 
or CoCl2 with zVAD-fmk (caspase inhibitor), necrostatin-1 
F I G U R E  3  Reactive oxygen species (ROS) and mitochondrial membrane potential (ΔΨm) in undifferentiated SH-SY5Y cells after exposure 
to Co NPs and CoCl2. A-B, Intracellular oxidized DCF fluorescence measured after 1 hour of exposure to the indicated concentrations of Co NPs 
and CoCl2, respectively. C, TMRE staining shows loss of ΔΨm after exposure to Co NPs and CoCl2 for 6 hours (20 and 50 µg/mL). Confocal 
microscopy of cells stained with TMRE (red) after 6 hours: control (D), CCCP (50 µM) (E), Co NPs (50 µg/mL) (F), and CoCl2 (50 µg/mL) (G). 
Blue fluorescence corresponds to nuclear staining with DAPI
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(RIP1/3 kinase inhibitor), or wortmannin (PI3K inhibitor) 
(data not shown). However, liproxstatin-1, a lipid antioxi-
dant that is known to suppress ferroptosis, partially pre-
vented Co NP-triggered cell death (Figure 7F) and reduced 
CoCl2-triggered cell death (Figure S3C,G). Furthermore, 
co-exposure with the iron chelator, deferoxamine, partially 
reduced cell death triggered by Co NPs (Figure 7F) as well 
as cell death in cells exposed to the Co salt (Figure S3D,H). 
Co NPs and CoCl2 also triggered lipid peroxidation, as 
determined by spectrophotometric analysis of SH-SY5Y 
cells stained with C11-BODIPY581/591 (Figure 7A,B). 
Furthermore, the dose-dependent increase in lipid peroxi-
dation after Co NP and CoCl2 exposure was counteracted 
upon co-incubation with liproxstatin-1. These results were 
further confirmed by confocal microscopy of exposed 
cells (Figure 7C-E). Lipid peroxidation-dependent cell 
death is believed to be regulated by GPX4, and neuron-
specific GPX4 depletion causes neurodegeneration.23 We, 
therefore, asked whether Co exposure had any effect on 
GPX4 expression. Indeed, as shown in Figure 6D, GPX4 
was decreased in SH-SY5Y cells exposed to Co NPs and 
CoCl2. We also noted a significant decrease in GPX4 
protein expression in cells exposed to Co NPs and CoCl2 
(20  µg/mL), but not when cells were exposed to WC or 
WC-Co NPs (Figure 6F, and Figure S4). We then asked 
whether the alterations in GSH content were related to 
the cystine/glutamate antiporter, system Xc-. As shown in 
Figure 6E, the system Xc- subunit SLC7A11 was upregu-
lated in cells after exposure to Co NPs and CoCl2 (20 µg/
mL), but not WC or WC-Co NPs.
3.7 | Potential link between Co and PD
Using the computational tool, insideNANO, we recently 
highlighted a potential association of several metal and 
F I G U R E  4  Cytosolic calcium elevation in undifferentiated SH-SY5Y cells after exposure to Co NPs and CoCl2. A, Increase in intracellular 
calcium levels measured by using the calcium-specific fluorescent probe, Fluo-4-AM, after 1 hour of exposure. Increase in intracellular calcium 
levels at 1 hour was verified by using the ratiometric dye, Fura 2, for cells maintained in regular cell culture medium (20 µg/mL) (B) versus cells 
maintained in calcium-free medium (50 µg/mL) (C). Data are mean values ± SD *P < .05. Statistical significance values were determined by 
applying Tukey's post hoc multiple comparison test
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metal oxide NPs and neurodegenerative disorders, includ-
ing PD.12 One of the intriguing observations was the as-
sociation, based on commonalities between transcriptional 
signatures, between WC and Co NPs, on the one hand, with 
MPTP and levodopa (L-dopa) on the other hand.12 The 
corresponding results are depicted in Figure S5A. WC-Co 
F I G U R E  5  Calcium-dependent cell death in Co-exposed SH-SY5Y cells. Metabolic activity of undifferentiated cells after exposure to Co 
NPs or CoCl2 (20 or 50 µg/mL) for 24 hours in the presence or absence of calcium chelators: A-B, EGTA (1 mM), C-D, EDTA (1 mM), and E-F, 
BAPTA-AM (5 μM). Data are mean values ± SD (n = 3). *P < .05, **P < .01. Statistical significance determined by applying Tukey's post hoc 
multiple comparison test
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NPs showed the most significant correlation with PD with 
a similarity index (SI) between NP and chemical (MPTP) 
of 0.99, while the SI between drug (L-dopa) and NP was 
0.75.12 The database did not contain data on Co NPs, only 
WC-Co NPs. Nevertheless, to further explore these asso-
ciations, we retrieved the gene expression data from which 
these similarities had been computed. As shown in Figure 
S5B, RAF1 (a proto-oncogene) and NEFH (neurofilament 
heavy) genes were found to be upregulated in the case of 
WC-Co NPs and MPTP and were downregulated in re-
sponse to L-dopa. We then evaluated the expression of these 
genes in RA-differentiated SH-SY5Y cells, an accepted in 
vitro model of dopaminergic neurons.19 To this end, cells 
were exposed to a sub-cytotoxic dose (5  µg/mL) of WC, 
F I G U R E  6  Co depletes the antioxidant, glutathione (GSH), leading to death of undifferentiated SH-SY5Y cells. GSH level in the cells after 
6 hours of exposure with Co NPs (A) and CoCl2 (B). C, Supplementation of cells with N-acetyl cysteine (NAC, 2.5 mM) rescued Co-mediated 
cell death at 12 hours. Co NPs and CoCl2 reduced the protein and gene expression of ferroptosis regulators after 24 hours of exposure at 20 µg/
mL: RT-PCR for GPX4 (D), and SLC7A11 (E), and quantification of western blot results for GPX4 protein (F) (refer to Suppl. Figure S4). Data 
shown are mean values ± SD (n = 3). *P < .05, **P < .01, **P < .001. Statistical significance determined by applying Tukey's post hoc multiple 
comparison test
(A) (B)
(C) (D)
(E) (F)
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WC-Co, and Co NPs versus CoCl2 and the expression of 
RAF1 and NEFH mRNA was determined by RT-PCR at day 
6 of differentiation. WC-Co and Co NP as well as CoCl2 ex-
posed cells showed upregulation of both genes with respect 
to control, thereby validating the in silico predictions, while 
no changes in the expression of these genes were seen in 
WC NP-exposed cells (Figure S5C,D).
3.8 | Co induces cell death and axonal 
disintegration
To verify the findings obtained using the SH-SY5Y cell line, 
we performed experiments in primary dopaminergic neu-
rons derived from a human iPSC line. The mature dopamin-
ergic neurons at day 12 of differentiation contained >90% 
F I G U R E  7  Co causes ferroptosis-like cell death (oxytosis) in undifferentiated SH-SY5Y cells. A-B, Lipid peroxidation in cells exposed 
to Co NPs and CoCl2 at 20 µg/mL was determined by using the C11-BODIPY581/591 assay. The relative C11-BODIPY581/591 fluorescence was 
quantified in cells exposed to Co NPs (A) and CoCl2 (B) in the presence and absence of Lip-1 (10 µM). Below are representative examples of cells 
stained with the C11-BODIPY581/591 probe: C, control, D, Co NPs, E, CoCl2. The shift from red to green fluorescence is reflective of the oxidation 
of the C11-BODIPY581/591 probe. F, The lipid antioxidant, liproxstatin-1 (Lip-1, 10 µM), and the iron-chelating agent, deferoxamine (DFO, 10 µM), 
partially prevented Co NP-induced cell death. Data shown as mean values ± SD *P < .05, **P < .01, **P < .001. Statistical significance between 
Lip-1 and DFO preexposed and unexposed groups determined by applying Tukey's multiple comparison test
(A)
(F)
(C) (D) (E)
(B)
   | 15GUPTA eT Al.
of Tuj-1 (neuronal class III β-tubulin) positive and >30% 
of TH-positive cells and displayed a well-developed axonal 
network (Figure 8). Importantly, a significant decrease in 
metabolic activity of 4-day dopaminergic precursors was 
observed following exposure to 20 µg/mL of Co NPs and 
its corresponding salt (CoCl2) while no cytotoxicity was de-
tected for WC and WC-Co NPs (Figure 9A). Furthermore, 
a decrease in GSH levels was detected in dopaminergic 
precursors exposed to Co NPs and the Co salt at 20  µg/
mL (Figure 9B). Additionally, 12-day mature dopaminer-
gic neurons also showed a significant decrease in cell vi-
ability after Co NPs and Co salt exposure, albeit less than 
that observed in 4-day DOPA precursors (Figure 9C). GSH 
depletion in mature dopaminergic neurons was, however, 
more pronounced than in the 4-day precursor neurons after 
Co NP and Co salt exposure (Figure 9D). It is worth not-
ing that low-dose exposure (5 µg/mL) elicited an increased 
metabolic activity in mature DOPA neurons while no dif-
ferences were seen in the DOPA precursors (Figure 9A,C). 
Optical micrographs of both 4-day and 12-day neurons 
showed dying/dead cells with altered axonal network after 
Co NP and CoCl2 exposure (20 µg/mL). Untreated cells, on 
the contrary, were intact and displayed well-developed neu-
rites and axonal network (Figure 9E). Finally, a higher dose 
of exposure (50 µg/mL) to Co NPs and CoCl2 triggered a 
further increase in cytotoxicity of mature DOPA neurons, as 
determined by the Alamar blue assay, with complete disin-
tegration of the axonal network and a rounding or blebbing 
of the cell soma (Figure S6A-D). We could not test the other 
NPs (WC and WC-Co) at this dose due to a limitation in the 
number of cells.
4 |  DISCUSSION
We have shown herein that Co NPs and Co salt trig-
ger dose-dependent cell death in neuronal cells through 
a non-apoptotic mechanism involving lipid peroxidation 
and depletion of GSH with downregulation of GPX4. 
Furthermore, when cells were exposed to a sub-cytotoxic 
dose of Co-containing NPs or Co salt, gene expression 
changes occurred that mirrored the changes observed in 
response to MPTP that yields PD-like symptoms in mice 
and humans. These results are relevant in light of previous 
case reports suggesting an association between Co poison-
ing and neurological disease.24
It is generally believed that Co2+ ions are able to pro-
duce hydroxyl radicals in the presence of hydrogen perox-
ide through a Fenton-like mechanism.25 Furthermore, in 
the presence of WC particles, the reduction of oxygen in 
ROS by Co is catalyzed at the surface of WC particles lead-
ing to the release of large amounts of Co2+ ions.26 Indeed, 
previous studies by Lison and coworkers have shown that 
WC-Co powder is more toxic toward murine macrophages 
in vitro than pure Co metal particles and that the cellular 
uptake of Co is enhanced when the metal is present in the 
form of WC-Co mixture.27,28 Furthermore, the authors found 
that cellular Co uptake was higher when the metal was pre-
sented to macrophages as WC-Co as compared to Co alone. 
However, there was no relationship between the cellular 
uptake of Co and toxicity, indicating that increased bio-
availability of Co is not the sole mechanism by which hard 
metal particles exhibit their cellular toxicity.29 These stud-
ies were all conducted with professional phagocytic cells 
F I G U R E  8  Primary dopaminergic precursors (day 4) and mature dopaminergic neurons (day 12) were derived from a human iPSC line. 
Mature DOPA neurons were positive for tyrosine hydroxylase (TH) and Tuj-1 (neuronal class III-tubulin). Cell nuclei visualized with DAPI
Tuj-1 (neuronal class III-tubulin) degreMIPAD)esalyxordyhenisoryt(HT
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F I G U R E  9  Co is cytotoxic for primary dopaminergic neurons. A, Metabolic activity, as determined by using the Alamar blue assay, 
and B, cellular GSH levels in differentiating DOPA precursor cells exposed for 24 hours to WC NPs, WC-Co NPs, Co NPs, and CoCl2. C, 
Metabolic activity and D, cellular GSH level of mature DOPA neurons exposed for 24 hours to WC NPs, WC-Co NPs, Co NPs, and CoCl2. E, 
Optical micrographs showing morphological features of DOPA precursors and mature DOPA neurons after exposure to 20 µg/mL of NPs or 
CoCl2. Red arrows indicate axons and white arrows indicate dead or dying cells. Data in panel (A to D) are mean values ± SD (n = 3). *P < .05, 
**P < .01, **P < .001. Statistical significance determined by applying Tukey's post hoc multiple comparison test
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(macrophages). In contrast, in the present study, we found 
that NPs of Co elicited a drastic reduction in cell viability of 
neuronal cells while the impact of WC-Co NPs (5 wt% Co) 
was very modest and pure WC NPs were found to be non- 
cytotoxic. Moreover, ICP-MS analysis showed that the cellu-
lar content of Co was greater when cells were exposed to Co 
NPs as compared with the corresponding amount of CoCl2 
while Co NPs and CoCl2 displayed a similar degree of tox-
icity in all three cell models (ie, undifferentiated, differenti-
ating, and differentiated SH-SY5Y cells) thus underscoring 
that cellular content alone does not dictate the outcome. The 
bioavailability and/or subcellular compartmentalization of 
Co may certainly also come into play. TEM analysis sug-
gested that Co NPs were enclosed in vesicles/endosomes 
while it is reasonable to assume that the metal ions are freely 
diffusible in the cell. The present study also suggests that 
cellular differentiation status may play a role as undiffer-
entiated SH-SY5Y cells appeared to be more sensitive to 
Co NPs and CoCl2 when compared to differentiated cells. 
Notably, a previous study has shown that the transcription 
factor Nrf2, a master regulator of the antioxidant response, 
is induced in SH-SY5Y cells upon RA-dependent neuronal 
differentiation.30 Interestingly, a recent study has shown that 
silencing of Nrf2 aggravated the cell death induced in PC-12 
cells by Co NPs and CoCl2.11
Does oxidative stress play a role in Co-induced toxicity? 
Nyga et al31 studied the toxicity of Co NPs using the macro-
phage-like U937 cell line, as well as human alveolar macro-
phages and monocyte-derived macrophages. They found that 
replenishing intracellular ascorbate reduced cytotoxicity and 
mitigated the inflammatory response while the addition of 
GSH had no effect on the Co-NP-induced cytotoxicity. On 
the contrary, Co NPs induced ROS formation in a concen-
tration-dependent manner, and this was prevented by both 
ascorbic acid and GSH, suggesting that the ability of ascor-
bic acid to protect against Co NP-induced cytotoxicity was 
independent of its antioxidant activity.31 In the present study, 
we found that Co NPs and CoCl2-triggered ROS production 
and a dissipation of the mitochondrial membrane potential 
(at relatively high doses) yet ascorbic acid and mitoTEMPO 
did not afford any protection. Therefore, our current view is 
that while mitochondrial damage and ROS production may 
be considered as features of Co-induced cell death, these 
events are not the main instigators of cell death. Instead, a 
pronounced depletion of GSH levels was evidenced in cells 
exposed to Co NPs and CoCl2, and the addition of NAC or 
GSH partially restored cell viability in exposed cells. Thus, 
oxidative stress, as indicated by the loss of GSH, plays an 
important role in the present model. Fenoglio et al32 previ-
ously reported on the oxidation of GSH by hard metal dusts. 
This might lead to an irreversible depletion of antioxidant 
defenses, if this were to occur in cells. Co and WC alone, 
however, did not exhibit any reactivity toward GSH, and such 
a mechanism is unlikely to explain the depletion of GSH in 
the present model.
GSH levels are significantly depleted in the substantia 
nigra in PD.33 Furthermore, using an in vitro model, Li et al34 
reported more than 20 years ago that a decrease in GSH trig-
gers the activation of neuronal 12-lipoxygenase (12-LOX), 
which leads to the production of peroxides, influx of calcium, 
and subsequent cell death, suggesting a role for lipid perox-
idation in neurodegeneration. Notably, in the present study, 
we have shown that Co NPs and Co salt elicit an influx of 
calcium in the neuronal SH-SY5Y cell line, and calcium 
chelators partially rescued the cells from Co-induced cell 
death. We also found that the lipid antioxidant, liproxsta-
tin-1 reduced CoCl2-mediated cell death and also afforded 
protection against Co NP-triggered cell death. Liproxstatin-1 
was originally identified in a small molecule screen for ferro-
ptosis inhibitors35 and has been suggested to act as a radical 
trapping antioxidant36; it suppresses ferroptosis in Gpx4-
deficient mice35 and was recently shown to rescue the mu-
rine hippocampal cell line HT-22 from glutamate-triggered 
cell death.37 In the present study, we provide evidence that 
Co-induced neurotoxicity transpires with a pronounced GSH 
depletion, along with calcium influx and lipid peroxidation. 
Moreover, we found that iron chelation suppressed Co-
induced cell death, though the effects of deferoxamine and 
liproxstatin-1 were fairly modest. We can exclude apoptosis 
as the cells did not display any of the characteristic morpho-
logical features of apoptosis; moreover, the pan-caspase in-
hibitor, zVAD-fmk was not able to rescue the cells. Similarly, 
the necroptosis inhibitor, necrostatin-1 failed to block cell 
death. Instead, we observed mitochondrial swelling in cells 
exposed to Co NPs and the presence of fibrillary structures 
in the cytoplasm. Interestingly, glutamate-induced neurotox-
icity is also accompanied by swollen mitochondria while the 
nuclei of glutamate-treated cells remain intact.38 Taken to-
gether, our findings are indicative of a ferroptosis-like mode 
of cell death. Ferroptosis is defined as an iron-dependent 
form of regulated cell death that is linked to the accrual of 
lipid peroxides.39 GPX4 has emerged as the main endoge-
nous inhibitor of ferroptosis by virtue of its ability to limit 
lipid peroxidation; additionally, inhibition of the cystine/glu-
tamate antiporter system xc− and the consequent decrease in 
GSH also triggers ferroptosis.40 However, it is important to 
consider the fact that oxidative stress-induced death of neu-
ronal cells with depletion of cellular GSH levels, referred to 
as oxytosis, was described in 2001, more than a decade be-
fore the first report on ferroptosis41 and that the molecular 
pathways involved in the regulation of ferroptosis and oxy-
tosis are very similar—if not identical.42 Hence, both forms 
of cell death are regulated, non-apoptotic modes of cell death 
that are intimately linked to GSH depletion and calcium in-
flux, and 12-LOX-mediated peroxidation appears to play a 
central role in the subsequent cell death.42 It is pertinent to 
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note that we have shown here that Co-induced neurotoxicity 
is associated with a decrease in GPX4 expression both at the 
protein and mRNA level (indicating that Co exerts transcrip-
tional effects in neuronal cells), thus implicating GPX4 in the 
regulation of oxytosis. Loss of GPX4 may compromise the 
cellular antioxidant defense leading to the accumulation of 
lethal lipid peroxides. Contrary to our expectations, we also 
observed an upregulation of the cystine/glutamate antiporter, 
system Xc-, encoded by SLC7A11. In light of the depletion of 
GSH, we expected that the antiporter system would be down-
regulated. However, this could perhaps represent a compen-
satory mechanism resulting from the marked depletion of 
GSH in Co-exposed cells. The antiporter system Xc- imports 
the amino acid cystine (the oxidized form of cysteine) into 
cells and exports glutamate. Cysteine, in turn, is the rate-lim-
iting substrate in the synthesis of GSH.43 Glutamate-induced 
neurotoxicity occurs when system Xc- is inhibited44 and it has 
been suggested that this cell death is a prototypic example of 
oxytosis.43 Thus, Co elicits oxytosis, a ferroptosis-like mode 
of cell death, in neuronal cells, with features that resemble 
those of neuronal cells undergoing regulated cell death in 
neurodegenerative diseases. It is interesting to note that sev-
eral genes that are involved in ferroptosis/oxytosis, including 
those encoding system Xc- (SLC7A11) and GPX4, are tran-
scriptionally regulated by Nrf2.44 Nrf2 can also increase the 
expression of the multidrug resistance protein 1 (MRP1) that 
was shown recently to promote GSH efflux, thereby enhanc-
ing ferroptosis, which could counterbalance the protective 
effects of Nrf2-dependent GSH synthesis.45 Further studies 
are required to pinpoint the role of Nrf2 in cell death, and 
whether transcriptional regulation by Nrf2 plays a role in fer-
roptosis/oxytosis in neurodegenerative disease.
It deserves to be mentioned that previous studies of oxy-
tosis have shown that CoCl2 protects against oxytosis at 
20-50 µM and that this protection was suggested to be de-
pendent on its ability to block calcium influx.34,46,47 While 
in these studies, CoCl2 alone did show some toxicity, it still 
provided significant protection against oxytosis. However, 
we believe that these apparent discrepancies are related to the 
dose of CoCl2. Hence, 20-50 µM of CoCl234,46 is likely too 
low to induce cytotoxicity, as toxicity was not observed in 
SH-SY5Y cells at 24 hours at 5 µg/mL (~20 µM) in the pres-
ent study. In fact, in experiments using primary human dopa-
minergic neurons, we noted an increase in metabolic activity 
at 5 µg/mL, while cell viability was significantly decreased 
at doses of 20 and 50 µg/mL. Furthermore, it is important to 
consider not only the dose, but also the duration of exposure. 
Indeed, it is possible that long-term and/or repeated exposure 
at higher doses of Co NPs or CoCl2 leads to ferroptosis/oxy-
tosis, as shown in the present study.
Bastian et al10 previously reported on the in vitro toxicity 
of WC and WC-Co (10 wt% Co) NPs and found that WC NPs 
did not yield any cytotoxicity up to 30 μg/mL after 3 days 
of exposure, while exposure to WC-Co NPs elicited slight 
toxicity for primary astrocytes derived from fetal rat corti-
ces. Primary cortical neurons, on the contrary, were found 
to be resistant. Using iPSC-derived dopaminergic precur-
sors and mature dopaminergic neurons, we show for the first 
time that Co NPs elicit significant cytotoxicity in primary 
human neurons along with a marked depletion of GSH levels. 
WC and WC-Co (5 wt% Co) were non-toxic in our model. 
Furthermore, we observed a loss of axonal integrity espe-
cially at high doses (50 μg/mL). Loss of the axonal network 
is considered a cardinal feature of the early stages of PD.48,49 
Other authors have presented evidence for a necroptosis-de-
pendent pathway of axonal degeneration in an animal model 
of PD.49 The present study does not refute this suggestion, 
though we can unequivocally conclude that cell death with 
loss of axonal integrity is linked to GSH depletion. It is inter-
esting to note that the ablation of Gpx4 in forebrain neurons 
in mice was found to promote cognitive impairment and neu-
ronal cell death with markers of ferroptosis (including lipid 
peroxidation),50 further supporting the link between neuro-
degeneration and ferroptosis. Taken together, our results ob-
tained in primary dopaminergic neurons serve to validate the 
results obtained using the SH-SY5Y model, and point toward 
a marked susceptibility of dopaminergic neurons and their 
precursors to Co.
To conclude, the present study demonstrated that Co 
NPs trigger dose-dependent cytotoxicity in a human neu-
ronal cell line while WC NPs were non-cytotoxic and Co-
doped WC NPs were only mildly cytotoxic. These findings 
were recapitulated in primary human dopaminergic neurons 
derived from iPS cells. Co salt (CoCl2) was also markedly 
cytotoxic and the Co NPs were found to undergo rapid dis-
solution in cell culture; therefore, the toxicity of Co NPs in 
the present study is most likely associated with the release 
of Co2+ ions. Furthermore, our investigations have shown 
that the cell death displayed features of ferroptosis (referred 
to as oxytosis in earlier publications)42 with depletion of the 
key cellular antioxidant, GSH as well as downregulation of 
GPX4. Furthermore, liproxstatin-1, a potent inhibitor of lipid 
peroxidation,35 partially rescued the cells from Co-induced 
cell death, lending further support to a ferroptosis-like 
mechanism.
Could the present findings have any implications for human 
neurodegenerative diseases? Using the recently developed 
computational tool referred to as insideNANO,12 we noted 
that Co-containing NPs were strongly linked to PD. The in sil-
ico-based predictions with respect to gene expression changes 
were validated in our in vitro model; however, the latter results 
are inferences based on similarities in gene expression profiles 
between different compounds, and do not constitute evidence 
per se of a link between Co poisoning and loss of dopami-
nergic neurons in the brain. On the contrary, the present ob-
servation that primary human dopaminergic neurons cultured 
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ex vivo are susceptible to Co NPs and Co salt with loss of 
axonal integrity shows that Co is, in fact, neurotoxic. Taken 
together, our results suggest that Co NPs may exert detrimen-
tal effects in neuronal cells, in particular in cells differentiated 
into dopaminergic neurons. Further studies are thus warranted 
to explore the potential link between Co-exposure and PD in 
humans. This is important in light of inadvertent occupational 
exposure to hard metals containing Co,2 and biomedical appli-
cations including hip implants.4
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